1. n-3 Polyunsaturated Fatty Acid Supplementation Affects Oxidative Stress Marker Levels in Patients with Type II Intestinal Failure: A Randomized Double Blind Trial
- Author
-
Adriana Flores-López, Martha Guevara-Cruz, Azalia Avila-Nava, Alejandro G. González-Garay, Luis E. González-Salazar, Ana L. Reyes-Ramírez, José Pedraza-Chaverri, Omar N. Medina-Campos, Isabel Medina-Vera, Juan G. Reyes-García, Armando R. Tovar, and Aurora E. Serralde-Zúñiga
- Subjects
intestinal failure ,oxidative stress ,n-3 polyunsaturated fatty acids ,fish oil ,parenteral nutrition ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Type II intestinal failure (IF-II) is a condition in which the gastrointestinal tract is compromised. Liver complications may occur because of the pathology and/or prolonged use of parenteral nutrition (PN); oxidative stress has been implicated as one of the causes. Lipid emulsions containing n-3 polyunsaturated fatty acids (PUFAs) have been proposed for the treatment. We aimed to evaluate the effect of 7-day n-3 PUFA supplementation on oxidative stress in IF-II patients receiving PN. This was a randomized, controlled, double-blinded, pilot trial of adult patients with IF-II, receiving either conventional PN (control) or PN enriched with n-3 PUFAs (intervention). Twenty patients were included (14 men, 49 ± 16.9 years), with the ANCOVA analysis the glucose (p = 0.003), and direct bilirubin (p = 0.001) levels reduced; whereas the high-density lipoprotein cholesterol (HDL-C) increased (p = 0.017). In the random-effect linear regression analysis, a reduction (p < 0.0001) in the malondialdehyde (MDA) level was found in the intervention group when the covariables age, HDL-C level, and alanine aminotransferase activity were considered. After 1 week of PN supplementation with n-3 PUFAs, the marker levels of some oxidative stress, blood lipids, and hepatic biomarkers improved in patients with IF-II.
- Published
- 2023
- Full Text
- View/download PDF